3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-liumbromide (MTT) assay results suggested that upregulation of WBP2 enhanced cell proliferation of glioma cells (Fig. 2a–d), while depletion of WBP2 inhibited cell proliferation. The gene discussed is WBP2; the disease is glioma.